Manufacturing

AstraZeneca teams up with G42 Healthcare to increase drug production in Abu Dhabi

AstraZeneca has signed a strategic partnership agreement with G42 Healthcare to manufacture medicinal therapies in Abu Dhabi. The agreement concentrates on teamwork...

Breyanzi’s case strengthened by Bristol Myers amidst the confrontation with Gilead

A year ago when Breyanzi’s second-line LBCL (large B-cell lymphoma) key data was revealed by Bristol Myers Squibb which found that a...

Biopharma newcomer Resilience buys AstraZeneca’s Ohio facility

AstraZeneca’s Ohio facility, which was part of the United States covid vaccine production network, has new ownership. The sale...

Novo Nordisk expands facility to increase production

Novo Nordisk will invest $744 million to expand its clinical production facilities in a Copenhagen suburb. Novo Nordisk is...

FDA hits BMS facility in Pheonix with warning letter following contamination issues

A Bristol Myers Squibb manufacturing facility has been issued a warning letter by the Food and Drug Administration (FDA) following contamination problems....

Institut Pasteur de Dakar of Senegal strikes manufacturing deal for Rubella and Measles vaccine

Institut Pasteur de Dakar (IPD) is a private entity from Senegal that aims to benefit public well-being in the continent through training,...

Adragos acquires Sanofi facility in Japan in bid to expand production network

Adragos Pharma is a German pharmaceutical Contract Development and Manufacturing Organization (CDMO), which has recently acquired Sanofi’s 50-year-old manufacturing plant in Kawagoe,...

Kite Gets Green Light For Commercial Production At Viral Vector Facility

Kite, a Gilead Company, has announced that the U.S. Food and Drug Administration (FDA) has given it the go-ahead to begin commercial...

Latest news

FDA and CDC exploring unlikely relation between COVID-19 vaccine and stroke

The FDA and CDC have brought out new revelations that the revised COVID-19 injection from Pfizer Inc...

Disappointing sales prompt AstraZeneca to pull out leukemia drug Lumoxiti from U.S. market

In a letter shared with healthcare providers, AstraZeneca has announced that it will be pulling its leukemia...

Sanofi’s Venture Capital units to receive over $750 million in investment to boost firm’s investment capabilities 

After a successful last year in which Sanofi Ventures made its second-highest number of deals, 10 rounds...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you

Amazon Inches Closer to Acquiring One Medical

Amazon has moved closer to finalizing its...

Singapore based Engine Biosciences raises $43M to grow its digital drug discovery

Drug discovery and development is a vast and rapidly expanding domain that includes both aspiring entrepreneurs and multi-billion dollars holding large pharmaceutical companies.

Softbank now has $5B stake in Roche for its ability to develop drugs using data

The Japanese multinational group, SoftBank Group Corp.,...